Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NAZANIN FIROOZ

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1447437967
CMS profile
65231
Location
WOODLAND HILLS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$2,534.53

140 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,534.53 140

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NAZANIN FIROOZ

NPI 1447437967 · CMS profile ID 65231

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

WOODLAND HILLS, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447437967?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NAZANIN FIROOZ, NPI 1447437967, CMS profile ID 65231. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447437967?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). NAZANIN FIROOZ, NPI 1447437967, CMS profile ID 65231. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447437967?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
NAZANIN FIROOZ, NPI 1447437967, CMS profile ID 65231, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1447437967?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

140 matching records · $2,534.53 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 140 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 140.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $20.1208/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830153697 CMS
Lilly USA, LLC $18.1008/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818660105 CMS
Novartis Pharmaceuticals Corporation $24.8408/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812678073 CMS
GlaxoSmithKline, LLC. $27.8408/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802406469 CMS
UCB, Inc. $3.9208/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807469099 CMS
Amgen Inc. $21.5007/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653721 CMS
Amgen Inc. $26.5907/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653649 CMS
Lilly USA, LLC $18.9207/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818672771 CMS
E.R. Squibb & Sons, L.L.C. $22.3307/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783455593 CMS
AbbVie Inc. $18.1007/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472139 CMS
Novartis Pharmaceuticals Corporation $31.2107/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812678071 CMS
Novartis Pharmaceuticals Corporation $31.3607/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812678075 CMS
Novartis Pharmaceuticals Corporation $4.0107/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812678077 CMS
Novartis Pharmaceuticals Corporation $7.6207/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812678079 CMS
Novartis Pharmaceuticals Corporation $10.7207/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812678091 CMS
GlaxoSmithKline, LLC. $25.0907/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802346707 CMS
Lilly USA, LLC $10.3707/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818660103 CMS
AstraZeneca Pharmaceuticals LP $17.8007/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829369135 CMS
AbbVie Inc. $23.5907/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472135 CMS
AbbVie Inc. $16.9007/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472131 CMS
Janssen Biotech, Inc. $18.3507/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788247995 CMS
UCB, Inc. $30.6707/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807318831 CMS
Lilly USA, LLC $24.5007/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818614109 CMS
AbbVie Inc. $17.4006/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472127 CMS
Novartis Pharmaceuticals Corporation $35.7406/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812678069 CMS
UCB, Inc. $6.6806/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807400107 CMS
Amgen Inc. $15.2606/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653669 CMS
AbbVie Inc. $23.2706/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472123 CMS
Amgen Inc. $12.7006/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653717 CMS
Genentech USA, Inc. $21.7606/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835957319 CMS
UCB, Inc. $4.5306/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807399915 CMS
Horizon Therapeutics plc $20.9206/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797123583 CMS
GlaxoSmithKline, LLC. $19.5506/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803017661 CMS
Lilly USA, LLC $17.5806/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818660101 CMS
AbbVie Inc. $24.9206/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472119 CMS
Janssen Biotech, Inc. $18.0506/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788248005 CMS
Amgen Inc. $16.7505/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653665 CMS
Amgen Inc. $17.5505/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653713 CMS
AbbVie Inc. $24.8105/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472115 CMS
AbbVie Inc. $7.0805/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472111 CMS
Amgen Inc. $20.3905/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653709 CMS
GlaxoSmithKline, LLC. $0.7405/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802867231 CMS
GlaxoSmithKline, LLC. $24.7205/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803189193 CMS
Janssen Biotech, Inc. $10.2905/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788248003 CMS
Merck Sharp & Dohme Corporation $21.1005/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848586167 CMS
AbbVie Inc. $20.0004/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472107 CMS
AbbVie Inc. $27.1404/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472103 CMS
Lilly USA, LLC $25.4304/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818669011 CMS
AbbVie Inc. $25.8104/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794472099 CMS
Amgen Inc. $8.2004/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825653701 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $21,293.42 154
PY2020 $4,089.83 133
PY2021 $2,534.53 140
PY2022 $3,433.52 180
PY2023 $3,829.27 171
PY2024 $3,640.44 158
PY2025 $10,407.30 176

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $272,609.90 6
PY2024 Principal investigator $169,568.04 6
PY2023 Recipient $610.01 1
PY2023 Principal investigator $332,483.27 11
PY2022 Principal investigator $270,137.72 8
PY2021 Principal investigator $40,093.45 15
PY2020 Recipient $2,902.53 3
PY2020 Principal investigator $52,598.08 43
PY2019 Recipient $4,941.02 2
PY2019 Principal investigator $56,421.61 17

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $6,003.63 09/02/2025 Non-covered Recipient Entity
CENTER FOR RHEUMATOLOGY RESEARCH
A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR) No dispute reported 06/30/2026 1190310633
Principal investigator 1 ABBVIE INC. $1,100.00 08/05/2025 Non-covered Recipient Entity
CENTER FOR RHEUMATOLOGY RSRCH LLC
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202501310
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,700.00 05/22/2025 Non-covered Recipient Entity
CENTER FOR RHEUMATOLOGY RESEARCH
An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment No dispute reported 06/30/2026 1190310302
Principal investigator 1 Novartis Pharmaceuticals Corporation $256,080.36 02/10/2025 Non-covered Recipient Entity
CENTER FOR RHEUMATOLOGY RESEARCH
A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR) No dispute reported 06/30/2026 1190310306
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,263.19 01/21/2025 Non-covered Recipient Entity
Center For Rheumatology Research
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) No dispute reported 06/30/2026 1235998216
Principal investigator 1 Novartis Pharmaceuticals Corporation $5,462.72 01/15/2025 Non-covered Recipient Entity
CENTER FOR RHEUMATOLOGY RESEARCH
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Pol No dispute reported 06/30/2026 1190310304